title: Applications of the CRISPR-Cas9 system in cancer biology.
abstract: The prokaryotic type II CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPR-associated 9) system is rapidly revolutionizing the field of genetic engineering, allowing researchers to alter the genomes of a large range of organisms with relative ease. Experimental approaches based on this versatile technology have the potential to transform the field of cancer genetics. Here, we review current approaches for functional studies of cancer genes that are based on CRISPR-Cas, with emphasis on their applicability for the development of next-generation models of human cancer.
authors.affiliation: David H. Koch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Sánchez-Rivera
authors.affiliation: 1] David H. Koch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA. [2] Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
authors.forename: Tyler
authors.initials: T
authors.lastname: Jacks
mesh_terms: D000818:Animals; D064113:CRISPR-Cas Systems / Q000235:genetics*; D004720:Endonucleases / Q000235:genetics*; D052138:Genes, Neoplasm; D016158:Genes, p53; D005818:Genetic Engineering; D006801:Humans; D008957:Models, Genetic; D009369:Neoplasms / Q000235:genetics*; D034622:RNA Interference; D013297:Streptococcus pyogenes / Q000235:genetics
chemical_list: D004720:Endonucleases